back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-26 17:29 Tx date 2023-05-24 |
$ABUS
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$140,800
+55,000 vol $2.56 each |
236,000 | |
| Filed 2022-05-26 22:09 Tx date 2022-05-25 |
$ABUS
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,250
+41,000 vol $2.25 each |
181,000 | |
| Filed 2021-06-07 20:24 Tx date 2021-06-03 |
$ABUS
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,900
+22,000 vol $2.95 each |
140,000 | |
| Filed 2020-06-01 17:44 Tx date 2020-05-28 |
$ABUS
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,520
+22,000 vol $2.16 each |
118,000 | |
| Filed 2019-08-20 16:30 Tx date 2019-08-17 |
$ABUS
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,000
+22,000 vol $1.50 each |
96,000 | |
| Filed 2018-06-22 Tx date 2018-06-19 |
$ABUS
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$148,500
+22,000 vol $6.75 each |
74,000 | |
| Filed 2017-06-22 Tx date 2017-06-21 |
$ABUS
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$78,100
+22,000 vol $3.55 each |
52,000 | |
| Filed 2016-06-03 Tx date 2016-06-03 |
$ABUS
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$29,925
+7,500 vol $3.99 each |
30,000 | |
| Filed 2016-01-29 Tx date 2015-08-24 |
$TKMR
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,950
+1,000 vol $6.95 each |
1,000 | |
| Filed 2016-01-29 Tx date 2014-12-17 |
$TKMR
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-27 Tx date 2015-08-12 |
$TKMR
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$68,325
+7,500 vol $9.11 each |
22,500 | |
| Filed 2016-01-27 Tx date 2015-03-30 |
$TKMR
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$263,550
+15,000 vol $17.57 each |
15,000 | |
| Filed 2016-01-27 Tx date 2014-12-17 |
$TKMR
Arbutus Biopharma Corporation |
Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|